| Autor: |
Mir TH; Department of Nephrology, Government Medical College, Srinagar, Jammu and Kashmir, India.; Department of Nephrology, Khyber Medical Institute Nowpora, Srinagar, Jammu and Kashmir, India., Zargar PA; Department of Cardiology, Government Medical College, Srinagar, Jammu and Kashmir, India., Sharma A; Department of Renal Pathology, Dr. Lal Path lab/National Reference lab, New Delhi, India., Jabeen B; Department of Radiology, SMHS Hospital, Srinagar, Jammu and Kashmir, India., Sharma S; Department of Renal Pathology, Dr. Lal Path lab/National Reference lab, New Delhi, India., Parvaiz MO; Department of Medicine, Holy Family Red Crescent Medical College, Dhaka, Bangladesh., Bashir S; Department of Nephrology, Khyber Medical Institute Nowpora, Srinagar, Jammu and Kashmir, India., Javeed R; Department of Nephrology, Government Medical College, Srinagar, Jammu and Kashmir, India. |
| Abstrakt: |
Coronavirus disease 2019 (COVID-19) pandemic has taken the world by a storm, posing a gruelling challenge to the medical fraternity globally. Besides its very high infectivityinfectivity, significant organ dysfunction occurs in critically ill COVID-19 patients, leading to severe morbidity and mortality. Pulmonary involvement is the leading cause of death in these patients to be followed by the cardiovascular involvement. Kidney involvement due to COVID-19 is becoming more discernible with AKI adversely affecting the outcome. Besides AKI, a few cases of collapsing FSGS in genetically vulnerable patients and thrombotic microangiopathies have been reported as well. We report a case of AA amyloidosis of the kidney with a rapidly progressive renal failure and congestive heart failure with preserved left ventricular functions, which complicated a moderate COVID-19 pneumonia providing some clues to a possible association of this novel virus disease with this complication, which needs to be confirmed in future studies. |
